Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings

被引：32

作者：

Biellik, Robin ^{[2
]}

Levin, Carol

Mugisha, Emmanuel ^{[3
]}

LaMontagne, D. Scott ^{[1
]}

Bingham, Allison

Kaipilyawar, Satish ^{[4
]}

Gandhi, Sanjay ^{[5
]}

机构：

[1] PATH, Reprod Hlth, Seattle, WA 98107 USA

[2] PATH, CH-1278 La Rippe, Switzerland

[3] PATH, Kampala, Uganda

[4] PATH, Commissionerate Family Welf, Hyderabad 500095, Andhra Pradesh, India

[5] PATH, Bombay 400093, Maharashtra, India

来源：

VACCINE | 2009年 / 27卷 / 44期

基金：

比尔及梅琳达.盖茨基金会;

关键词：

HPV vaccine; Health system; Vaccine delivery; PARTICLE VACCINE; YOUNG-WOMEN; DOUBLE-BLIND; EFFICACY; TYPE-18; INFECTION; ISSUES;

D O I：

10.1016/j.vaccine.2009.08.003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This descriptive qualitative study synthesizes health system and immunization financing assessments performed through formative research in India, Peru, Uganda, and Vietnam using a non-probability sample of national and sub-national stakeholders; and recommends appropriate and effective strategies for HPV vaccine delivery in low-resource settings. We conclude that maximum feasibility and acceptability and lowest cost for delivering HPV vaccine can be achieved by implementing through national immunization programs; by partnering with other sectors, such as education and maternal-child health; by strengthening existing human resources and cold chain infrastructures where needed; and finally, by considering schools for reaching the target population. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：6203 / 6209

页数：7

共 34 条

[1] Introducing HPV vaccine in developing countries - Key challenges and issues [J].